EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,865,430 | -23.6% | 2,768,836 | +3.4% | 0.00% | -25.0% |
| Q2 2023 | $20,754,423 | +12.1% | 2,677,990 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $18,514,173 | -27.5% | 2,775,738 | -2.8% | 0.00% | -33.3% |
| Q4 2022 | $25,522,976 | -6.1% | 2,854,919 | +3.4% | 0.01% | 0.0% |
| Q3 2022 | $27,175,000 | +34.5% | 2,761,724 | +8.8% | 0.01% | +20.0% |
| Q2 2022 | $20,202,000 | -21.1% | 2,538,018 | -3.9% | 0.01% | 0.0% |
| Q1 2022 | $25,606,000 | -31.8% | 2,639,800 | +7.4% | 0.01% | -37.5% |
| Q4 2021 | $37,565,000 | -6.7% | 2,458,441 | +1.4% | 0.01% | 0.0% |
| Q3 2021 | $40,258,000 | -21.4% | 2,425,184 | -1.4% | 0.01% | -27.3% |
| Q2 2021 | $51,195,000 | -33.9% | 2,460,151 | +3.3% | 0.01% | -42.1% |
| Q1 2021 | $77,419,000 | – | 2,382,148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |